Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136 | 345 | 680 | 2,049 | 2,787 |
| Marketable Securities | N/A | N/A | N/A | 0 | 50 |
| Receivables | 4 | 6 | 42 | 28 | 76 |
| Inventories | N/A | N/A | 0 | 26 | N/A |
| TOTAL | $180 | $396 | $744 | $3,209 | $4,404 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 0 | 164 | 6 |
| Investments And Advances | N/A | N/A | 0 | 703 | 62 |
| Intangibles | N/A | N/A | 0 | 5,902 | N/A |
| Other Non-Current Assets | 5 | 5 | 25 | 0 | 0 |
| TOTAL | $5 | $5 | $25 | $6,769 | $69 |
| Total Assets | $185 | $401 | $769 | $9,978 | $4,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17 | 85 | 155 | 928 | 728 |
| TOTAL | $17 | $85 | $155 | $928 | $728 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 23 | 0 | 0 | 0 | 0 |
| TOTAL | $23 | $0 | $0 | $0 | $0 |
| Total Liabilities | $40 | $85 | $155 | $928 | $728 |
| Shareholders' Equity | |||||
| Common Shares | 20,108 | 19,961 | 19,354 | 19,354 | 7,147 |
| Retained earnings | -20,925 | -21,308 | -21,611 | -13,546 | -4,660 |
| Other shareholders' equity | 962 | 1,663 | 2,872 | 3,243 | 1,258 |
| TOTAL | $145 | $316 | $615 | $9,050 | $3,745 |
| Total Liabilities And Equity | $185 | $401 | $769 | $9,978 | $4,473 |